Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01056484 · ClinicalTrials.gov registry record · Phase 2

Mindfulness Meditation for Health

A Phase 2 study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
Phase 2
Development phase
123
Enrollment target

NCT01056484 is a Phase 2 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 123 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01056484, a Phase 2 study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
Phase 2
Development phase
123 participants
Enrollment target

Study Summary

The purpose of this 52-week clinical trial is to see if the meditation-based intervention, adjunctive to standard of care therapy, can reduce relapse and improve psychological health among adults recovering from alcohol dependence.

Interventions

  • BEHAVIORAL Mindfulness Based Relapse Prevention for Alcohol Dependence
  • OTHER "Wait-list" control

Trial Details

FieldValue
Enrollment Target 123 participants
Start Date 2009-09
Est. Completion 2013-05
Phase Phase 2

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT01056484

The ClinicalTrials.gov registry entry for NCT01056484 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Mindfulness Based Relapse Prevention for Alcohol Dependence is the first listed.

NCT01056484 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01056484 about?

NCT01056484 is a clinical study titled "Mindfulness Meditation for Health". The purpose of this 52-week clinical trial is to see if the meditation-based intervention, adjunctive to standard of care therapy, can reduce relapse and improve psychological health among adults recovering from alcohol dependence.

What is the current status of trial NCT01056484?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 123 participants. The study started on 2009-09. Estimated completion is 2013-05.

What interventions are being tested in trial NCT01056484?

The interventions under investigation include: Mindfulness Based Relapse Prevention for Alcohol Dependence (BEHAVIORAL), "Wait-list" control (OTHER).

Who is sponsoring clinical trial NCT01056484?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.